Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 05/31/17
Due: 05/31/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| 480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions | NCT01403077 | 480 Biomedical | user2@example.com | None | 2011-10-31 | 2015-10-31 | 2016-10-31 | - | - | 2025-07-14 |
| Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System | NCT02097082 | 480 Biomedical | user2@example.com | None | 2013-10-31 | 2017-05-31 | 2018-05-31 | - | - | 2025-07-14 |